Wubin Pan
Fondatore presso CONNECT BIOPHARMA HOLDINGS LIMITED
Patrimonio netto: 8 M $ in data 30/04/2024
Posizioni attive di Wubin Pan
Società | Posizione | Inizio | Fine |
---|---|---|---|
CONNECT BIOPHARMA HOLDINGS LIMITED | Presidente | 01/05/2012 | - |
Fondatore | 01/05/2012 | - | |
Presidente | 01/05/2012 | - | |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Presidente | 02/05/2012 | - |
Fondatore | 02/05/2012 | - | |
Presidente | 02/05/2012 | - | |
Connect Biopharma HongKong Ltd. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Wubin Pan
Precedenti posizioni note di Wubin Pan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Direttore operativo | 01/01/2006 | 01/10/2011 |
Fondatore | 01/01/2006 | 01/10/2011 | |
CROWN BIOSCIENCE INTERNATIONAL | Fondatore | 01/07/2006 | 01/10/2011 |
Shenzhen Yuanxing Biomedical Technology Co., Ltd.
Shenzhen Yuanxing Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Tsinghua Yuanxing Biotechnology, Inc. is engaged in the development of biological and pharmaceutical products. It is involved in the research and development, commercialization of adenoviral vector vaccine. The company was founded on December 4, 2000 and is headquartered in Shenzhen, China. | Corporate Officer/Principal | 01/11/2000 | 01/05/2006 |
Terragen Discovery, Inc.
Terragen Discovery, Inc. Pharmaceuticals: MajorHealth Technology Part of Cubist Pharmaceuticals LLC, Terragen Discovery, Inc. is a developer of antibiotics and patent drugs. The company is based in Vancouver, Canada. Terragen Discovery was acquired by Cubist Pharmaceuticals LLC on October 26, 2000 for $25.61 million. | Corporate Officer/Principal | - | - |
Formazione di Wubin Pan
University of Sussex | Doctorate Degree |
Tsinghua University | Masters Business Admin |
Sun Yat-Sen University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Cina | 5 |
Stati Uniti | 2 |
Canada | 2 |
Posizioni
Founder | 4 |
Corporate Officer/Principal | 2 |
Chairman | 2 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
Aziende private | 6 |
---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Terragen Discovery, Inc.
Terragen Discovery, Inc. Pharmaceuticals: MajorHealth Technology Part of Cubist Pharmaceuticals LLC, Terragen Discovery, Inc. is a developer of antibiotics and patent drugs. The company is based in Vancouver, Canada. Terragen Discovery was acquired by Cubist Pharmaceuticals LLC on October 26, 2000 for $25.61 million. | Health Technology |
Shenzhen Yuanxing Biomedical Technology Co., Ltd.
Shenzhen Yuanxing Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Tsinghua Yuanxing Biotechnology, Inc. is engaged in the development of biological and pharmaceutical products. It is involved in the research and development, commercialization of adenoviral vector vaccine. The company was founded on December 4, 2000 and is headquartered in Shenzhen, China. | Health Technology |
Crown Bioscience International
Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Health Technology |
Connect Biopharma HongKong Ltd. |
- Borsa valori
- Insiders
- Wubin Pan
- Esperienza